Price-to-Sales Ratio

Two computation routes exist and they must agree. On a per-share basis, divide the current market price by revenue per share, where revenue per share is total sales for the period divided by the weighted average number of shares outstanding over that same period. On an aggregate basis, divide market capitalisation by total revenue. Discrepancies almost always trace to a share-count mismatch: a price taken today against a share count from an earlier balance sheet date, or a company with multiple share classes where only the listed class is counted.

The denominator is normally trailing twelve-month revenue, though forward P/S using consensus next-year sales is common for high-growth names. Whichever convention is chosen, it must be applied identically across every company in the comparable set, and revenue must be measured the same way: gross billings versus net commission revenue for agency-model businesses can differ by an order of magnitude.

Rearranging a constant-growth dividend discount model shows what the multiple is compensation for. Divide both sides of the model by sales per share and the justified trailing P/S becomes the net profit margin multiplied by the payout ratio multiplied by one plus the growth rate, all divided by the required return on equity minus the growth rate. Every driver of P/E survives (payout, growth, risk) with net profit margin added as an explicit term.

That term is the whole point. Two firms with identical growth, risk and payout policy should trade at P/S ratios in proportion to their margins. A distributor earning a one percent net margin and a software firm earning twenty percent are not comparable on sales multiples in any meaningful sense. This is why analysts frequently regress observed P/S against net or operating margin across an industry and read residuals as relative cheapness rather than comparing raw multiples.

P/S is standard practice in retail, distribution, telecommunications, airlines and other sales-driven or deeply cyclical sectors, and in any situation where earnings are temporarily negative: restructurings, early-stage growth companies, and trough-of-cycle industrials. Because revenue is the least volatile line on the income statement, the multiple is far more stable through a cycle than P/E, which makes time-series comparisons against a company's own history more informative.

The structural weakness is a claim mismatch. Market capitalisation is the equity claim only, while revenue is generated by assets funded by both debt and equity. A highly levered firm will therefore screen cheap on P/S purely because leverage has shrunk the numerator's share of the enterprise. Enterprise value to sales (market value of equity plus net debt over revenue) removes that distortion and is the preferred sales-based multiple whenever capital structures differ materially across the peer group.

Be able to compute the ratio from either a per-share income statement or a market capitalisation figure, and to recognise which revenue definition and share count belong in each. Be able to derive and apply the justified trailing P/S expression from the constant-growth model, and to state that a lower margin, lower growth, lower payout or higher required return each lowers the multiple a company deserves.

Be able to argue both sides. The advantages: revenue is always positive, it is less prone to the smoothing and one-off charges that distort earnings, and the multiple is comparatively stable. The disadvantages: it is silent on cost structure and profitability, it ignores capital structure, and revenue recognition choices still allow considerable discretion. A candidate should also be able to explain when enterprise value to sales dominates P/S, and why sales multiples must always be read alongside margin trends rather than in isolation.